HOOKIPA Pharma Inc (NAS:HOOK) Stock News, Headlines & Updates
HOOKIPA Pharma Inc Stock News from GuruFocus
- 1
Jul 01, 2024
HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV
GlobeNewswire • 5:00pm
HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV
Marketwired • 4:00pm
Jun 04, 2024
HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting
Marketwired • 1:00pm
May 30, 2024
HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting
Marketwired • 4:00pm
May 23, 2024
HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting
Marketwired • 5:00pm
May 09, 2024
HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
Marketwired • 7:00am
Apr 25, 2024
HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
Marketwired • 7:00am
Apr 24, 2024
HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers
Marketwired • 7:00am
Apr 16, 2024
HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 4:00pm
Apr 10, 2024
HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration
Marketwired • 7:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news